Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Japan flag Japan · Delayed Price · Currency is JPY
2,210.00
-2.00 (-0.09%)
At close: Mar 6, 2026
0.50%
Market Cap 95.21B
Revenue (ttm) 86.61B
Net Income (ttm) 7.26B
Shares Out 43.08M
EPS (ttm) 164.78
PE Ratio 13.41
Forward PE 10.48
Dividend 48.00 (2.17%)
Ex-Dividend Date Mar 30, 2026
Volume 73,700
Average Volume 110,805
Open 2,195.00
Previous Close 2,212.00
Day's Range 2,178.00 - 2,213.00
52-Week Range 1,878.00 - 2,378.00
Beta 0.03
RSI 57.64
Earnings Date May 7, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e... [Read more]

Sector Healthcare
Founded 1955
Employees 1,746
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4559
Full Company Profile

Financial Performance

In fiscal year 2025, Zeria Pharmaceutical's revenue was 87.31 billion, an increase of 15.30% compared to the previous year's 75.73 billion. Earnings were 9.94 billion, an increase of 28.52%.

Financial Statements

News

There is no news available yet.